This inventor holds 3 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Allergan, Inc.. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Yong-Xin Li: Innovator in Pharmaceutical Compositions
Introduction
Yong-Xin Li is a notable inventor based in Mission Viejo, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating various disorders. With a total of 3 patents to his name, his work has the potential to impact many lives.
Latest Patents
Li's latest patents include innovative pharmaceutical compositions that utilize D-serine transporter inhibitors. One of his inventions focuses on the treatment of visual system disorders, providing therapeutic methods that enhance visual function. Another patent addresses central nervous system disorders, showcasing the versatility and importance of D-serine transporter inhibitors in medical applications.
Career Highlights
Yong-Xin Li is currently associated with Allergan, Inc., a company known for its commitment to developing innovative healthcare solutions. His work at Allergan has allowed him to explore and expand the potential of pharmaceutical compositions, contributing to advancements in treatment methodologies.
Collaborations
Throughout his career, Li has collaborated with esteemed colleagues such as Alan C Foster and Ursula V Staubli. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic approaches.
Conclusion
Yong-Xin Li's contributions to the field of pharmaceuticals through his innovative patents highlight his dedication to improving healthcare. His work continues to pave the way for new treatments that can significantly benefit patients with visual and central nervous system disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile